Keywords: urinary bladder neoplasms; neoadjuvant therapy; cystectomy; time factorsGC, gemcitabine and cisplatin; MIBC, muscle invasive bladder cancer; MVAC, methotrexate, vinblastine, doxorubicin and cisplatin; NAC, neoadjuvant chemotherapy; OS, overall survival; R
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: urinary bladder; carcinoma; drug therapy; neoplasm invasiveness; cystectomyCSS, cancer specific survival; cT0, clinical complete response; MIBC, muscle invasive bladder cancer; MVAC, methotrexate, vinblastine, doxorubicin and cisplatin; NC, neoadjuvant ch
Keywords: urinary bladder neoplasms; neoplasm metastasis; lymph nodes; genomics; biomarkers, tumorFFPE, formalin fixed, paraffin embedded; LN, lymph node; MIBC, muscle invasive bladder cancer; NAC, neoadjuvant chemotherapy; PLND, pelvic lymph node dissection; TURBT
Significant Role of Lifetime Cigarette Smoking in Worsening Bladder Cancer and Upper Tract Urothelial Carcinoma Prognosis: A Meta-Analysis
Keywords: urinary bladder neoplasms; carcinoma; transitional cell; smoking; prognosis; meta-analysisBC, bladder cancer; DSS, disease specific survival; MIBC, muscle invasive bladder cancer; NMIBC, nonmuscle invasive bladder cancer; PFS, progression-free survival; R
The Effect of Concomitant Carcinoma In Situ on Neoadjuvant Chemotherapy for Urothelial Cell Carcinoma of the Bladder: Inferior Pathological Outcomes but No Effect on Survival
Keywords: urinary bladder; carcinoma in situ; urothelium; neoadjuvant therapy; drug therapycCIS, concomitant CIS; CIS, carcinoma in situ; CSS, cancer specific survival; MIBC, muscle invasive bladder cancer; MVAC, methotrexate, vincristine, doxorubicin and cisplatin
Muscle Invasive Bladder Cancer: Examining Survivor Burden and Unmet Needs
Keywords: urinary bladder neoplasms; neoplasm invasiveness; survivors; health services needs and demands; quality of lifeBC, bladder cancer; ISMMS, Icahn School of Medicine at Mount Sinai; ITM, illness trajectory model; MIBC, muscle invasive bladder cancer; QOL, qu
Pathological T0 Following Radical Cystectomy with or without Neoadjuvant Chemotherapy: A Useful Surrogate
Keywords: urinary bladder neoplasms; neoadjuvant therapy; drug therapy; cystectomy; risk assessmentAC, adjuvant chemotherapy; CT, computerized tomography; MIBC, muscle invasive bladder cancer; MRC, Medical Research Council; MVAC, Methotrexate/vinblastine/doxorubici
Intravesical Gemcitabine for High Risk, Nonmuscle Invasive Bladder Cancer after Bacillus Calmette-Guérin Treatment Failure
Keywords: urinary bladder; urinary bladder neoplasms; BCG vaccine; treatment failure; gemcitabineBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CR, complete response; CSS, cancer specific survival; MIBC, muscle invasive bladder cancer; NMIBC, nonMIBC; NR, n
Feasibility of Radical Transurethral Resection as Monotherapy for Selected Patients With Muscle Invasive Bladder Cancer
Keywords: urinary bladder neoplasms; age factors; treatment outcomeBCG, bacillus Calmette-Guerin; CTx, radical cystectomy; MIBC, muscle invasive bladder cancer; TUR, transurethral resection; TURBT, transurethral resection of bladder tumor